BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31192128)

  • 1. The Role of 5-ALA in Low-Grade Gliomas and the Influence of Antiepileptic Drugs on Intraoperative Fluorescence.
    Goryaynov SA; Widhalm G; Goldberg MF; Chelushkin D; Spallone A; Chernyshov KA; Ryzhova M; Pavlova G; Revischin A; Shishkina L; Jukov V; Savelieva T; Victor L; Potapov A
    Front Oncol; 2019; 9():423. PubMed ID: 31192128
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of Corticosteroids and Antiepileptic Drugs on Visible 5-Aminolevulinic Acid Fluorescence in a Series of Initially Suspected Low-Grade Gliomas Including World Health Organization Grade II, III, and IV Gliomas.
    Wadiura LI; Mischkulnig M; Hosmann A; Borkovec M; Kiesel B; Rötzer T; Mercea PA; Furtner J; Hervey-Jumper S; Rössler K; Berger MS; Widhalm G
    World Neurosurg; 2020 May; 137():e437-e446. PubMed ID: 32045726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas.
    Widhalm G; Olson J; Weller J; Bravo J; Han SJ; Phillips J; Hervey-Jumper SL; Chang SM; Roberts DW; Berger MS
    J Neurosurg; 2019 May; 133(1):79-88. PubMed ID: 31075771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
    Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
    J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers.
    Hosmann A; Millesi M; Wadiura LI; Kiesel B; Mercea PA; Mischkulnig M; Borkovec M; Furtner J; Roetzer T; Wolfsberger S; Phillips JJ; Berghoff AS; Hervey-Jumper S; Berger MS; Widhalm G
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers.
    Hosmann A; Jaber M; Roetzer-Pejrimovsky T; Timelthaler G; Borkovec M; Kiesel B; Wadiura LI; Millesi M; Mercea PA; Phillips J; Hervey-Jumper S; Berghoff AS; Hainfellner JA; Berger MS; Stummer W; Widhalm G
    J Neurosurg; 2023 May; 138(5):1281-1290. PubMed ID: 36115057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches.
    Kiesel B; Freund J; Reichert D; Wadiura L; Erkkilae MT; Woehrer A; Hervey-Jumper S; Berger MS; Widhalm G
    Front Oncol; 2021; 11():699301. PubMed ID: 34395266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.
    Millesi M; Kiesel B; Woehrer A; Hainfellner JA; Novak K; Martínez-Moreno M; Wolfsberger S; Knosp E; Widhalm G
    Neurosurg Focus; 2014 Feb; 36(2):E11. PubMed ID: 24484249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
    J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double dose of 5-aminolevulinic acid and its effect on protoporphyrin IX accumulation in low-grade glioma.
    Suero Molina E; Black D; Kaneko S; Müther M; Stummer W
    J Neurosurg; 2022 Oct; 137(4):943-952. PubMed ID: 35213830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement.
    Widhalm G; Kiesel B; Woehrer A; Traub-Weidinger T; Preusser M; Marosi C; Prayer D; Hainfellner JA; Knosp E; Wolfsberger S
    PLoS One; 2013; 8(10):e76988. PubMed ID: 24204718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas.
    Mischkulnig M; Roetzer-Pejrimovsky T; Lötsch-Gojo D; Kastner N; Bruckner K; Prihoda R; Lang A; Martinez-Moreno M; Furtner J; Berghoff A; Woehrer A; Berger W; Widhalm G; Kiesel B
    Front Med (Lausanne); 2022; 9():907442. PubMed ID: 35665365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
    Kaneko S; Suero Molina E; Sporns P; Schipmann S; Black D; Stummer W
    J Neurosurg; 2022 Jan; 136(1):9-15. PubMed ID: 34144512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of corticosteroid and antiepileptic drug treatment effects on heme biosynthesis mRNA expression in lower-grade gliomas: Potential implications for 5-ALA metabolization.
    Mischkulnig M; Sperl V; Erhart F; Kiesel B; Lang A; Hosmann A; Roetzer T; Makolli J; Traxler D; Borkovec M; Rössler K; Widhalm G; Wadiura LI
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102755. PubMed ID: 35149260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectroscopic measurement of 5-ALA-induced intracellular protoporphyrin IX in pediatric brain tumors.
    Schwake M; Kaneko S; Suero Molina E; Müther M; Schipmann S; Köchling M; Brentrup A; Stummer W
    Acta Neurochir (Wien); 2019 Oct; 161(10):2099-2105. PubMed ID: 31435824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
    Jaber M; Ewelt C; Wölfer J; Brokinkel B; Thomas C; Hasselblatt M; Grauer O; Stummer W
    Neurosurgery; 2019 Jun; 84(6):1214-1224. PubMed ID: 30107580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients.
    Kiesel B; Millesi M; Woehrer A; Furtner J; Bavand A; Roetzer T; Mischkulnig M; Wolfsberger S; Preusser M; Knosp E; Widhalm G
    Neurosurg Focus; 2018 Jun; 44(6):E7. PubMed ID: 29852770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-operative visualization of brain tumors with 5-aminolevulinic acid-induced fluorescence.
    Widhalm G
    Clin Neuropathol; 2014; 33(4):260-78. PubMed ID: 24986206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
    Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
    J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas.
    Sanai N; Snyder LA; Honea NJ; Coons SW; Eschbacher JM; Smith KA; Spetzler RF
    J Neurosurg; 2011 Oct; 115(4):740-8. PubMed ID: 21761971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.